Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1993 2
1994 1
1995 4
1997 1
1998 1
1999 2
2001 2
2002 4
2003 2
2004 4
2005 6
2006 11
2007 11
2008 15
2009 9
2010 8
2011 21
2012 14
2013 15
2014 21
2015 15
2016 25
2017 17
2018 32
2019 29
2020 27
2021 35
2022 51
2023 66
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

413 results

Results by year

Filters applied: . Clear all
Page 1
Cans.
Vu AT. Vu AT. J Adolesc Health. 2023 Mar 2:S1054-139X(23)00024-1. doi: 10.1016/j.jadohealth.2023.01.003. Online ahead of print. J Adolesc Health. 2023. PMID: 36870899 No abstract available.
Wonder.
Vu AT. Vu AT. J Adolesc Health. 2023 Oct;73(4):796. doi: 10.1016/j.jadohealth.2023.03.003. Epub 2023 May 23. J Adolesc Health. 2023. PMID: 37227339 No abstract available.
Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.
Pennington KM, Vu A, Challener D, Rivera CG, Shweta FNU, Zeuli JD, Temesgen Z. Pennington KM, et al. Among authors: vu a. J Clin Tuberc Other Mycobact Dis. 2021 May 8;24:100244. doi: 10.1016/j.jctube.2021.100244. eCollection 2021 Aug. J Clin Tuberc Other Mycobact Dis. 2021. PMID: 34036184 Free PMC article.
Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD.
Fang MY, Markmiller S, Vu AQ, Javaherian A, Dowdle WE, Jolivet P, Bushway PJ, Castello NA, Baral A, Chan MY, Linsley JW, Linsley D, Mercola M, Finkbeiner S, Lecuyer E, Lewcock JW, Yeo GW. Fang MY, et al. Among authors: vu aq. Neuron. 2019 Sep 4;103(5):802-819.e11. doi: 10.1016/j.neuron.2019.05.048. Epub 2019 Jul 1. Neuron. 2019. PMID: 31272829 Free PMC article.
Deucravacitinib in moderate-to-severe psoriasis.
Vu A, Maloney V, Gordon KB. Vu A, et al. Immunotherapy. 2022 Nov;14(16):1279-1290. doi: 10.2217/imt-2022-0109. Epub 2022 Nov 14. Immunotherapy. 2022. PMID: 36373503 Review.
New Directions in Pulmonary Gene Therapy.
Vu A, McCray PB , Jr. Vu A, et al. Hum Gene Ther. 2020 Sep;31(17-18):921-939. doi: 10.1089/hum.2020.166. Hum Gene Ther. 2020. PMID: 32814451 Free PMC article. Review.
Toll-like receptors in mycobacterial infection.
Vu A, Calzadilla A, Gidfar S, Calderon-Candelario R, Mirsaeidi M. Vu A, et al. Eur J Pharmacol. 2017 Aug 5;808:1-7. doi: 10.1016/j.ejphar.2016.10.018. Epub 2016 Oct 17. Eur J Pharmacol. 2017. PMID: 27756604 Review.
413 results